Acute demyelinating lesions with restricted diffusion in multiple sclerosis

Author(s): Balashov KE, Lindzen E

Abstract

Background and objectives:It is widely accepted that typical acute demyelinating lesions in relapsing-remitting multiple sclerosis (RRMS) exhibit vasogenic edema with increased diffusion, as demonstrated by an increased apparent diffusion coefficient on MRI. In contrast, acute ischemic lesions demonstrate cytotoxic edema with restricted diffusion. Recent reports have documented selected cases of acute demyelinating lesions exhibiting restricted diffusion (ADLRD) in MS. We aimed to assess the morphologies, distributions, signal characteristics and changes over time of nine ADLRD. An additional goal was to obtain clinical correlations and relate our findings to all previously published case reports describing ADLRD.

Methods:A retrospective case series study was performed at two academic centers. MRI characteristics of nine ADLRD found in six RRMS patients were compared with typical active symptomatic contrast-enhancing lesions with increased or normal diffusion in control RRMS patients.

Results:The average size of ADLRD was not significantly different from typical lesions. A periventricular location and faint signal on T2-weighted images were significantly more common for ADLRD compared with typical lesions. Two patients with ADLRD on initial MRI exhibited new ADLRD on their follow up scans.

Conclusion:Our results and review of prior published cases suggest that ADLRD represent a new variant of MS lesion. The restricted diffusion that is a characteristic of ADLRD on MRI is a new challenge in the differential diagnosis of stroke in young adults. The pathogenesis of ADLRD remains to be understood.

Similar Articles

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Author(s): Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al.

Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes

Author(s): Swanton JK, Fernando K, Dalton CM, Miszkiel KA, Thompson AJ, et al.

MRI criteria for MS in patients with clinically isolated syndromes

Author(s): Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, et al.

Plasma vitamin B12 status and cerebral white-matter lesions

Author(s): de Lau LM, Smith AD, Refsum H, Johnston C, Breteler MM

Migraine headache in middle age and late-life brain infarcts

Author(s): Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, et al.

Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis

Author(s): Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, et al.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis

Author(s): Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, et al.

Imaging of white matter lesions

Author(s): Barkhof F, Scheltens P

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Author(s): Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al.

Diffusion-weighted imaging in acute demyelinating myelopathy

Author(s): Zecca C, Cereda C, Wetzel S, Tschuor S, Staedler C, et al.